Some public health experts are worried FDA’s focus on annual COVID-19 shots is too narrow and they are calling on the administration and vaccine makers to expand their focus on next-generation vaccines that are better at preventing COVID-19 altogether rather than just updating the current vaccines to decrease symptoms of coronavirus. One of those experts, though, acknowledges that it might be a tough sell for vaccine makers, as the government soon might stop paying for the shots. The concerns come...